The Addition of Bevacizumab to FOLFOX4 Prolongs Survival in Relapsed Colorectal Cancer: Interim Data from the ECOG 3200 Trial.[J].G. Kesava Reddy;Vinay K. Jain.Clinical Colorectal Cancer.2005, 5
The Addition of Bevacizumab to FOLFOX4 Prolongs Survival in Relapsed Colorectal Cancer: Interim Data from the ECOG 3200 Trial.[J].G. Kesava Reddy;Vinay K. Jain.Clinical Colorectal Cancer.2005, 5